US PBM Medco plans its own head-to-head Plavix vs Effient trial
This article was originally published in Scrip
Executive Summary
The US pharmacy benefit manager Medco Health Solutions is launching its own 14,000-patient head-to-head trial comparing the effectiveness of Bristol-Myers Squibb/Sanofi-Aventis 's antiplatelet therapy Plavix (clopidogrel) against Lilly/Daiichi Sankyo's recently launched Effient (prasugrel).